1. Home
  2. AMRX vs SAM Comparison

AMRX vs SAM Comparison

Compare AMRX & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • SAM
  • Stock Information
  • Founded
  • AMRX 2002
  • SAM 1984
  • Country
  • AMRX United States
  • SAM United States
  • Employees
  • AMRX N/A
  • SAM N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • SAM Beverages (Production/Distribution)
  • Sector
  • AMRX Health Care
  • SAM Consumer Staples
  • Exchange
  • AMRX Nasdaq
  • SAM Nasdaq
  • Market Cap
  • AMRX 2.3B
  • SAM 2.7B
  • IPO Year
  • AMRX N/A
  • SAM 1995
  • Fundamental
  • Price
  • AMRX $7.32
  • SAM $229.76
  • Analyst Decision
  • AMRX Strong Buy
  • SAM Buy
  • Analyst Count
  • AMRX 4
  • SAM 9
  • Target Price
  • AMRX $11.50
  • SAM $287.50
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • SAM 131.2K
  • Earning Date
  • AMRX 05-02-2025
  • SAM 07-24-2025
  • Dividend Yield
  • AMRX N/A
  • SAM N/A
  • EPS Growth
  • AMRX N/A
  • SAM N/A
  • EPS
  • AMRX N/A
  • SAM 6.16
  • Revenue
  • AMRX $2,830,186,000.00
  • SAM $2,040,741,000.00
  • Revenue This Year
  • AMRX $10.20
  • SAM $2.79
  • Revenue Next Year
  • AMRX $7.15
  • SAM $2.61
  • P/E Ratio
  • AMRX N/A
  • SAM $37.29
  • Revenue Growth
  • AMRX 13.42
  • SAM 0.79
  • 52 Week Low
  • AMRX $6.29
  • SAM $215.10
  • 52 Week High
  • AMRX $9.48
  • SAM $339.77
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.61
  • SAM 40.46
  • Support Level
  • AMRX $7.02
  • SAM $230.50
  • Resistance Level
  • AMRX $7.39
  • SAM $236.30
  • Average True Range (ATR)
  • AMRX 0.18
  • SAM 5.11
  • MACD
  • AMRX -0.00
  • SAM -1.60
  • Stochastic Oscillator
  • AMRX 45.80
  • SAM 8.86

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Share on Social Networks: